MSB 11.8% $1.57 mesoblast limited

News Flash: 9 Analysts Think Mesoblast Limited (ASX:MSB) Earnings Are Under Threat, page-131

  1. 30,411 Posts.
    lightbulb Created with Sketch. 1863
    The overkill and sledging in your statements are telling.

    re-do trials agin [sic]

    Did you not notice the repetition?

    Nothing you say changes the reality that we are ahead. Certainly the America First types wanted to slow down the revolution in medical treatment.

    Too many snouts in the pharmaceutical drug trough to avoid it.

    Sure, a set back has happened.

    Nothing you say changes the reality that it's not the quality of our stem cells that caused the need.

    It's the widespread use of pharmaceutical drugs that caused it.

    Talk about retrograde thinking.

    Your insults are a massive mistake. They reflect very poorly on you indeed.



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.57
Change
-0.210(11.8%)
Mkt cap ! $1.792B
Open High Low Value Volume
$1.72 $1.74 $1.52 $15.63M 9.716M

Buyers (Bids)

No. Vol. Price($)
1 5127 $1.57
 

Sellers (Offers)

Price($) Vol. No.
$1.57 39613 3
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.